107 related articles for article (PubMed ID: 24151232)
1. BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC.
Diao H; Wang L; Huang J; Jiang M; Zhou H; Li X; Chen Q; Jiang Z; Feng H
J Cell Biochem; 2014 Apr; 115(4):641-50. PubMed ID: 24151232
[TBL] [Abstract][Full Text] [Related]
2. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
Wang L; Huang J; Jiang M; Sun L
J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
[TBL] [Abstract][Full Text] [Related]
3. Inhibited PTHLH downstream leukocyte adhesion-mediated protein amino acid N-linked glycosylation coupling Notch and JAK-STAT cascade to iron-sulfur cluster assembly-induced aging network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by systems-theoretical analysis.
Wang L; Huang J; Jiang M; Lin H; Qi L; Diao H
Integr Biol (Camb); 2012 Oct; 4(10):1256-62. PubMed ID: 22955522
[TBL] [Abstract][Full Text] [Related]
4. Adenosylmethionine decarboxylase 1 (AMD1)-mediated mRNA processing and cell adhesion activated & inhibited transition mechanisms by different comparisons between chimpanzee and human left hemisphere.
Wang L; Huang J; Jiang M; Diao H; Zhou H; Li X; Chen Q; Jiang Z; Feng H
Cell Biochem Biophys; 2014 Sep; 70(1):279-88. PubMed ID: 24652003
[TBL] [Abstract][Full Text] [Related]
5. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
[TBL] [Abstract][Full Text] [Related]
6. Cartilage oligomeric matrix protein (COMP)-mediated cell differentiation to proteolysis mechanism networks from human normal adjacent tissues to lung adenocarcinoma.
Wang L; Huang J; Jiang M; Diao H; Zhou H; Li X; Chen Q; Jiang Z; Feng H; Wolfl S
Anal Cell Pathol (Amst); 2013; 36(3-4):93-105. PubMed ID: 24064399
[TBL] [Abstract][Full Text] [Related]
7. CAMK1 phosphoinositide signal-mediated protein sorting and transport network in human hepatocellular carcinoma (HCC) by biocomputation.
Wang L; Huang J; Jiang M; Chen Q; Jiang Z; Feng H
Cell Biochem Biophys; 2014 Nov; 70(2):1011-6. PubMed ID: 24825433
[TBL] [Abstract][Full Text] [Related]
8. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
9. PTHLH coupling upstream negative regulation of fatty acid biosynthesis and Wnt receptor signal to downstream peptidase activity-induced apoptosis network in human hepatocellular carcinoma by systems-theoretical analysis.
Huang J; Wang L; Jiang M; Lin H; Qi L; Diao H
J Recept Signal Transduct Res; 2012 Oct; 32(5):250-6. PubMed ID: 22799769
[TBL] [Abstract][Full Text] [Related]
10. RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/cirrhotic liver tissues and human hepatocellular carcinoma (HCC).
Wang L; Huang J; Jiang M
Cell Physiol Biochem; 2010; 26(3):303-10. PubMed ID: 20798514
[TBL] [Abstract][Full Text] [Related]
11. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
13. E2F1 interactive with BRCA1 pathway induces HCC two different small molecule metabolism or cell cycle regulation via mitochondrion or CD4+T to cytosol.
Chen Q; Wang L; Jiang M; Huang J; Jiang Z; Feng H; Ji Z
J Cell Physiol; 2018 Feb; 233(2):1213-1221. PubMed ID: 28474358
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
[TBL] [Abstract][Full Text] [Related]
15. Effect of occult hepatitis B virus infection on the early-onset of hepatocellular carcinoma in patients with hepatitis C virus infection.
Nakano M; Kawaguchi T; Nakamoto S; Kawaguchi A; Kanda T; Imazeki F; Kuromatsu R; Sumie S; Satani M; Yamada S; Torimura T; Kakuma T; Yokosuka O; Sata M
Oncol Rep; 2013 Nov; 30(5):2049-55. PubMed ID: 23982634
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
17. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
18. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.
Wang L; Huang J; Jiang M; Zheng X
Tumour Biol; 2010 Oct; 31(5):417-25. PubMed ID: 20532728
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
20. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]